- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/519 - PyrimidinesHydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
Patent holdings for IPC class A61K 31/519
Total number of patents in this class: 20720
10-year publication summary
|
1394
|
1384
|
1578
|
1620
|
1714
|
1766
|
1655
|
1734
|
1833
|
657
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Incyte Corporation | 1063 |
306 |
| Novartis AG | 10340 |
283 |
| Boehringer Ingelheim International GmbH | 4494 |
253 |
| Janssen Pharmaceutica N.V. | 3217 |
175 |
| F. Hoffmann-La Roche AG | 7847 |
168 |
| AstraZeneca AB | 2823 |
166 |
| Taisho Pharmaceutical Co., Ltd. | 855 |
166 |
| Merck Sharp & Dohme LLC | 3736 |
164 |
| Pfizer Inc. | 3374 |
162 |
| Pharmacyclics LLC | 239 |
162 |
| The Regents of the University of California | 20594 |
159 |
| Gilead Sciences, Inc. | 2200 |
158 |
| Genentech, Inc. | 4090 |
153 |
| Hoffmann-La Roche Inc. | 3722 |
146 |
| Amgen Inc. | 4372 |
145 |
| Dana-Farber Cancer Institute, Inc. | 2648 |
145 |
| Bristol-myers Squibb Company | 4797 |
144 |
| Merck Patent GmbH | 5673 |
129 |
| Incyte Holdings Corporation | 627 |
129 |
| Takeda Pharmaceutical Company Limited | 2717 |
127 |
| Other owners | 17280 |